Study Evaluating The Safety And Tolerability Of ILV-094 In Subjects With Psoriasis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Pfizer CT.gov Call Center
Pfizer
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
24 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Stratical Medical
Edmonton, Alberta, Canada
- the Northern Alberta Clinical Trials and Research Centre (nactrc)
Edmonton, Alberta, Canada
- University of Alberta, Hospital Site Clinical Sciences Building
Edmonton, Alberta, Canada
- Bio Pharma Services Inc
Toronto, Ontario, Canada
- K. Papp Clinical Research
Waterloo, Ontario, Canada
- Innovaderm Recherches Inc
Montreal, Quebec, Canada
- Queen Mary Hospital
Hong Kong, Hong Kong
- Farmovs Parexel (pty) Ltd
Bloemfontein, Free State, South Africa
- Parexel George
George, Western Cape, South Africa
- David Stoll, Md
Beverly Hills, California, United States
- Dermatology Research
Santa Monica, California, United States
- Mra Clinical Research
South Miami, Florida, United States
- Miami Research Associates
South Miami, Florida, United States
- Hudson Dermatology
Evansville, Indiana, United States
- Dawes Fretzin Clinical Research Group
Indianapolis, Indiana, United States
- Dawes Fretzin Dermatology Group
Indianapolis, Indiana, United States
- Hamzavi Dermatology
Fort Gratiot, Michigan, United States
- Central Dermatology
St Louis, Missouri, United States
- Mount Sinai School of Medicine
New York, New York, United States
- New York University Medical Center
New York, New York, United States
- Duke Clinical Reseach Unit
Durham, North Carolina, United States
- the Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Altoona Center for Clinical Research
Duncansville, Pennsylvania, United States
- Baylor Research Institute
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Dec 2007
- Primary completion
- 14 Jun 2010
- Completion
- 14 Jun 2010
- Last update posted
- 23 Aug 2024
- Registered enrollment
- 76
- Registry id
- NCT00563524
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.